Zenas Biopharma Inc (ZBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -65,777 | -27,800 | -37,124 | -12,537 | -119,282 |
| Depreciation Amortization | 68 | 33 | 113 | 83 | 78 |
| Accounts payable and accrued liabilities | 2,927 | 3,407 | N/A | -3,538 | N/A |
| Other Working Capital | 12,021 | 6,865 | -8,039 | -15,606 | 7,967 |
| Other Operating Activity | 700 | -1,607 | 14,521 | 16,469 | 45,585 |
| Operating Cash Flow | $-50,061 | $-19,102 | $-30,529 | $-15,129 | $-65,652 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -57 | -22 | -17 | N/A | -198 |
| Net Acquisitions | N/A | N/A | 0 | N/A | -2,000 |
| Investing Cash Flow | $-57 | $-22 | $-17 | $N/A | $-2,198 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | 20,000 | N/A |
| Common Stock Issued | 166 | 42 | N/A | 66 | N/A |
| Other Financing Activity | 176,959 | -656 | 20,116 | 0 | 59,391 |
| Financing Cash Flow | $177,125 | $-614 | $20,116 | $20,066 | $59,391 |
| Exchange Rate Effect | 68 | 36 | 78 | 165 | -41 |
| Beginning Cash Position | 56,943 | 56,942 | 67,295 | 67,295 | 75,795 |
| End Cash Position | 184,018 | 37,240 | 56,943 | 72,397 | 67,295 |
| Net Cash Flow | $127,075 | $-19,702 | $-10,352 | $5,102 | $-8,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,061 | -19,102 | -30,529 | -15,129 | -65,652 |
| Capital Expenditure | -57 | -22 | N/A | N/A | N/A |
| Free Cash Flow | -50,118 | -19,124 | -30,529 | -15,129 | -65,652 |